好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

CSF Abnormalities and the Risk of Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndromes: A Meta-Analysis of Placebo Patients from the Interferon Beta and Glatiramer Acetate Clinically Isolated Syndrome Trials
MS and Related Diseases
(-)
119
Authors/Disclosures
Claire Riley, MD, FAAN Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Tiffany Cossey, MD (University of Texas, Houston) Dr. Cossey has nothing to disclose.
Jennifer Smrtka (Biogen) No disclosure on file
Shahram Khalid, MD (Neurology Care PLLC) No disclosure on file
Shuang Wang No disclosure on file
Helen Partridge No disclosure on file
Mark J. Tullman, MD (White Plains Hospital) Dr. Tullman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Tullman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Viela Bio.